Form 4 Filing for Camp4 Therapeutics Corp

This filing details a Form 4 submission for Camp4 Therapeutics Corp, reporting on a stock option grant to Chief Financial Officer Kelly Gold. The transaction, dated December 11, 2025, involved the acquisition of 190,000 stock options with a right to buy common stock at a price of $0.00. The options have a post-transaction ownership of 190,000 shares. The option vests starting December 1, 2025, with one-third vesting on the first anniversary and the remainder over the subsequent 24 months, contingent upon continued service. The option is exercisable with a conversion or exercise price of $6.01 and expires on December 10, 2035. The filing also notes that Kelly Gold is an officer of the company but not a director or ten-percent owner.